Targeted Therapies Improve Outcomes in Renal Cancer and GIST, but Challenges Remain

Targeted therapies have significantly changed the treatment of cancer and are now considered to be a component of care for a number of common malignancies, including breast, colorectal, and lung cancers. In particular, they have significantly improved outcomes for patients with metastatic renal cell carcinoma (mRCC) and advanced gastrointestinal stromal tumors (GIST).

FDA Warns About Injection Site Reactions With Naltrexone

Injectable, extended-release naltrexone (Vivitrol, Cephalon), used for the treatment of alcohol dependence, has been linked to adverse injection-site reactions, some requiring surgery, according to a US Food and Drug Administration (FDA) advisory notice to healthcare professionals released yesterday.

Growth Hormone Therapy May Decrease Diabetes Risk in Girls With Turner Syndrome

Growth hormone (GH) treatment has beneficial effects on body composition, regional fat deposition and glucose tolerance in girls with Turner syndrome, a study suggests. "We found that GH-treated girls were leaner, with less abdominal fat and normal glucose tolerance compared with never-treated girls in the current study and compared with Turner syndrome girls in studies […]